Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

UVA scientists discovered a molecule that blocks a key gene that drives glioblastoma, offering hope for a new treatment ...

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

In this video, Azka Ali, MD, medical oncologist at the Cleveland Clinic Taussig Cancer Institute, highlights interesting ...

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments ...

It’s not often that researchers get to share encouraging news when it comes to cancer. That’s why the recent announcement ...

The legal battle between Duke Health and WakeMed over a cancer-fighting linear accelerator has a David vs. Goliath flavor.

Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.